Generation, optimization and characterization of novel anti-prion compounds

Bioorg Med Chem. 2020 Nov 1;28(21):115717. doi: 10.1016/j.bmc.2020.115717. Epub 2020 Aug 25.

Abstract

Prions are misfolded proteins involved in neurodegenerative diseases of high interest in veterinary and public health. In this work, we report the chemical space exploration around the anti-prion compound BB 0300674 in order to gain an understanding of its Structure Activity Relationships (SARs). A series of 43 novel analogues, based on four different chemical clusters, were synthetized and tested against PrPSc and mutant PrP toxicity assays. From this biological screening, two compounds (59 and 65) emerged with a 10-fold improvement in anti-prion activity compared with the initial lead compound, presenting at the same time interesting cell viability.

Keywords: Lead optimization; PrP(C); PrP(Sc); Prion; Screening.

MeSH terms

  • Animals
  • Benzylamines / chemical synthesis
  • Benzylamines / chemistry*
  • Benzylamines / pharmacology
  • Blood-Brain Barrier / drug effects
  • Blood-Brain Barrier / metabolism
  • Cell Survival / drug effects
  • Drug Evaluation, Preclinical
  • HEK293 Cells
  • Humans
  • Mice
  • Mutagenesis
  • PrPSc Proteins / antagonists & inhibitors
  • PrPSc Proteins / genetics
  • PrPSc Proteins / metabolism*
  • Structure-Activity Relationship

Substances

  • Benzylamines
  • PrPSc Proteins